Macrocyclic polyketides have been subjects of great interest in synthe
tic and biosynthetic chemistry because of their structural complexity
and medicinal activities. With expression of the entire 6-deoxyerythro
nolide B synthase (DEBS) (10,283 amino acids) in a heterologous host,
substantial quantities of 6-deoxyerythronolide B (6dEB), the aglycone
of the macrolide antibiotic erythromycin, and 8,8a-deoxyoleandolide, a
14-membered lactone ring identical to 6dEB except for a methyl group
side chain in place of an ethyl unit, were synthesized in Streptomyces
coelicolor. The biosynthetic strategy utilizes a genetic approach tha
t facilitates rapid structural manipulation of DEBS or other modular p
olyketide synthases (PKSs), including those found in actinomycetes wit
h poorly developed genetic methods. From a technological viewpoint, th
is approach should allow the rational design of biosynthetic products
and may eventually lead to the generation of diverse polyketide librar
ies by means of combinatorial cloning of naturally occurring and mutan
t PKS modules.